Can a high-dose influenza vaccine cause swelling or lumps at the injection site or in nearby lymph nodes in an adult recipient?

Yes, high-dose flu shots can trigger swelling and lumps at the injection site and in nearby lymph nodes

Injection-site swelling is a well-documented adverse reaction to influenza vaccines, occurring in approximately 15-20% of recipients, with lymph node enlargement (adenopathy) developing in up to 16% of adults under 65 years of age. 1

Local Injection-Site Reactions

According to FDA labeling data, the following injection-site reactions are common:

• Swelling: Occurs in 14.5-19.9% of children and is documented in adult recipients 1
• Induration (hardness): Reported in 11.7-16.6% of vaccinated individuals 1
• Pain: The most common reaction, affecting >50% of adults and children 1
• Erythema (redness): Occurs in 27-32% of recipients 1

The swelling is typically:

• Moderate (2.5-5 cm) in most cases
• Severe (≥5 cm) in a small percentage
• Self-limited, resolving within 7 days in most individuals

Lymph Node Swelling (Adenopathy)

Axillary and supraclavicular lymph node swelling is a recognized immune response to deltoid muscle vaccination, occurring in up to 16% of adults aged 18-64 years after high-dose formulations. 1 This represents a normal immunologic response where vaccine antigens migrate to draining lymph nodes 2.

Key characteristics:

• Develops within 2-4 days post-vaccination
• Typically lasts 1-10 days (varies by vaccine formulation) 2
• Appears on the same side as the injection
• Can be detected on imaging studies (PET/CT, ultrasound) 3

Subcutaneous Nodules and Lipomas

Recent evidence suggests a more concerning association:

A 2025 multicenter study found that influenza vaccination is associated with increased risk of subcutaneous nodules (HR 1.32) and lipomas in the upper arm (HR 1.57). 4 These develop when:

• Vaccine is inadvertently administered subcutaneously rather than intramuscularly
• Particularly in patients with higher body mass where needle length may be insufficient
• Aluminum adjuvants trigger lymphoid follicular hyperplasia 5

These nodules can:

• Persist for months (resolution typically within 5 months) 6
• Mimic soft tissue masses or sarcomas on imaging 6
• Cause diagnostic confusion requiring biopsy consideration

Clinical Implications and Management

The key distinction is timing and location:

1. Expected reactions (within 7 days, injection site): Local swelling, induration, and ipsilateral axillary adenopathy are normal immune responses requiring only reassurance and symptomatic treatment 1

2. Persistent nodules (>1 month): Consider injection granuloma or lymphoid hyperplasia, especially if the mass is firm and non-tender 6, 5

3. Extensive limb swelling: Rare cases (26 reports in Dutch surveillance) show swelling extending beyond the shoulder or around the entire upper arm, resembling cellulitis but self-resolving with symptomatic treatment 7

Important Caveats

• Proper injection technique is critical: Intramuscular administration with appropriate needle length (based on body habitus) minimizes risk of persistent nodules 4, 6
• Document vaccination details: Always record date, site, and laterality for radiologic interpretation, as vaccine-related adenopathy can be mistaken for malignancy on imaging studies 2
• FDG-PET timing: Avoid scheduling within 7 days of vaccination to prevent false-positive lymph node uptake 3

The overwhelming majority of swelling and lumps are benign, self-limited reactions that do not contraindicate future vaccination. However, persistent masses warrant clinical follow-up to distinguish normal vaccine reactions from injection granulomas requiring observation versus other pathology.